Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Fish and Richardson
Express Scripts

Generated: October 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 5,177,080

« Back to Dashboard

Summary for Patent: 5,177,080

Title: Substituted pyridyl-dihydroxy-heptenoic acid and its salts
Abstract:Substituted pyridyl-dihydroxy-heptenoic acid of the formula ##STR1## and its salts, if desired in an isomeric form, have a superior inhibitory action on HMG-CoA reductase and thus bring about a surprisingly good lowering of the cholesterol content in the blood.
Inventor(s): Angerbauer; Rolf (Wuppertal, DE), Fey; Peter (Wuppertal, DE), Hubsch; Walter (Wuppertal, DE), Philipps; Thomas (Cologne, DE), Bischoff; Hilmar (Wuppertal, DE), Petzinna; Dieter (Duesseldorf, DE), Schmidt; Delf (Wuppertal, DE), Thomas; Gunter (Milan, IT)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:07/798,675
Patent Claim Types:
see list of patent claims
Compound; Use; Composition;

No matches for this query

Foreign Priority and PCT Information for Patent: 5,177,080

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany4040026Dec 14, 1990
Italy91 A/002125Jul 31, 1991

International Patent Family for Patent: 5,177,080

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Hungary221293► Subscribe
HungaryT61282► Subscribe
Hungary913945► Subscribe
Hong Kong1004552► Subscribe
Greece3020826► Subscribe
Finland101069► Subscribe
Finland915854► Subscribe
Spain2091852► Subscribe
European Patent Office0491226► Subscribe98C0026Belgium► Subscribe
Denmark0491226► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
US Department of Justice
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus